No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 1,737 | 2,082 | 2,588 | 2,928 | 2,648 | 2,763 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 99 | 188 | 227 | 110 | 43 | -81 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Tessenderlo Group N.V., a global entity established in 1919 and headquartered in Brussels, Belgium, is a subsidiary of Verbrugge NV. The company, which rebranded from Tessenderlo Chemie nv in June 2017, operates across four principal segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power, serving diverse end markets such as agriculture, food, industry, construction, health, and consumer goods. The Agro division is dedicated to the manufacturing, marketing, and distribution of essential crop nutrients, including liquid and potassium sulfate fertilizers sold under brands like Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluPotasse, and K-Leaf. Additionally, it provides crop protection products such as LINEX and VELPAR herbicides, SEVIN insecticide, and SECTAGON fumigant. Through its Bio-Valorization segment, Tessenderlo Group transforms bio-residuals into a range of valuable products like gelatins, collagen peptides, proteins, and fats. These are supplied to various sectors, including food, pharmaceutical, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions arm manufactures and supplies plastic pipe systems and chemicals for water treatment. This segment also encompasses other industrial activities, including the production and sale of mining and industrial auxiliaries, alongside specialized services for treating and disposing of produced and flowback water from oil and gas exploration, and recovering industrial process fluids. Finally, the T-Power segment focuses on energy generation, utilizing a 425 MW combined cycle gas turbine to produce electricity.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Tessenderlo Group N.V. (TESB.BR)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Tessenderlo Group N.V., a global entity established in 1919 and headquartered in Brussels, Belgium, is a subsidiary of Verbrugge NV. The company, which rebranded from Tessenderlo Chemie nv in June 2017, operates across four principal segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power, serving diverse end markets such as agriculture, food, industry, construction, health, and consumer goods. The Agro division is dedicated to the manufacturing, marketing, and distribution of essential crop nutrients, including liquid and potassium sulfate fertilizers sold under brands like Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluPotasse, and K-Leaf. Additionally, it provides crop protection products such as LINEX and VELPAR herbicides, SEVIN insecticide, and SECTAGON fumigant. Through its Bio-Valorization segment, Tessenderlo Group transforms bio-residuals into a range of valuable products like gelatins, collagen peptides, proteins, and fats. These are supplied to various sectors, including food, pharmaceutical, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions arm manufactures and supplies plastic pipe systems and chemicals for water treatment. This segment also encompasses other industrial activities, including the production and sale of mining and industrial auxiliaries, alongside specialized services for treating and disposing of produced and flowback water from oil and gas exploration, and recovering industrial process fluids. Finally, the T-Power segment focuses on energy generation, utilizing a 425 MW combined cycle gas turbine to produce electricity.